The Biomedical Advanced Research and Development Authority (BARDA) has issued a Sources Sought Notice (SSN) to gather insights from antibiotic developers working on solutions for drug-resistant bacterial infections. This SSN is part of BARDA’s Antimicrobial Resistance (AMR) Project BioShield, which focuses on understanding the current antibiotic landscape and potentially facilitating future acquisitions to combat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) and bloodstream infections (BSI).
Overview of Solicitation
BARDA’s SSN is a market research effort intended to collect information on the capabilities and status of antibiotics in development for treatment of drug-resistant infections. This project seeks input from businesses (both small and large) on their products and assesses the potential to expand indications to include biothreat pathogens.
Key Proposal Information
BARDA is specifically interested in:
- Antibiotic Programs with FDA Progress: Antibiotics targeting HABP, VABP, and BSI that have reached or will reach the end of Phase 2 by May 1, 2025.
- Biothreat Indications: Products that could potentially address biothreat pathogens (e.g., Yersinia pestis and Bacillus anthracis).
- Clinical and Manufacturing Details: Information on clinical studies, safety data, manufacturing capacity, and timelines for product availability.
- Commercialization Strategy: Respondents should detail their strategy for bringing products to market and ensuring sustainability.
Additional Considerations
This SSN emphasizes BARDA’s focus on supporting products with strong domestic manufacturing capabilities. The initiative also includes a clear confidentiality framework, allowing companies to submit proprietary information while protecting intellectual property rights.
Important Deadlines
- Questions Due: Questions regarding the SSN must be submitted by November 29, 2025, Noon EST.
- Response Submission: Final responses are due on the same day, November 29, 2025, Noon EST.
If your company has considered applying for BARDA funding, your federal funding journey starts here.
For additional information about EverGlade Consulting, reach out to: [email protected]
